36
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assess the Outcomes of Transcatheter Aortic Valve Replacement in Bicuspid Valve with Mixed Disease versus Predominant Aortic Stenosis

, , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 695-703 | Received 30 Oct 2023, Accepted 04 Apr 2024, Published online: 30 Apr 2024

References

  • Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616
  • Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484. doi:10.1016/S0140-6736(15)60308-7
  • Leon MB, Mack MJ, Hahn RT, et al. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. J Am Coll Cardiol. 2021;77(9):1149–1161. doi:10.1016/j.jacc.2020.12.052
  • Vincent F, Ternacle J, Denimal T, et al. Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis. Circulation. 2021;143(10):1043–1061. doi:10.1161/CIRCULATIONAHA.120.048048
  • Forrest JK, Kaple RK, Ramlawi B, et al. Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT Registry. JACC: Cardiovasc Interv. 2020;13(15):1749–1759. doi:10.1016/j.jcin.2020.03.022
  • Yoon SH, Bleiziffer S, De Backer O, et al. Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. J Am Coll Cardiol. 2017;69(21):2579–2589. doi:10.1016/j.jacc.2017.03.017
  • Egbe AC, Luis SA, Padang R, et al. Outcomes in Moderate Mixed Aortic Valve Disease: is it Time for a Paradigm Shift? J Am Coll Cardiol. 2016;67(20):2321–2329. doi:10.1016/j.jacc.2016.03.509
  • Halim SA, Edwards FH, Dai D, et al. Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease: a Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2020;141(13):1071–1079. doi:10.1161/CIRCULATIONAHA.119.040333
  • Honda S, Kitai T, Okada Y, et al. Impact of aortic regurgitation on the prognosis of severe aortic stenosis. Heart. 2012;98(21):1591–1594. doi:10.1136/heartjnl-2012-302089
  • Egbe AC, Poterucha JT, Warnes CA. Mixed aortic valve disease: midterm outcome and predictors of adverse events. Eur Heart J. 2016;37(34):2671–2678. doi:10.1093/eurheartj/ehw079
  • Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395
  • Writing Committee M, Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: executive Summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):450–500. doi:10.1016/j.jacc.2020.11.035
  • Chieffo A, Van Mieghem NM, Tchetche D, et al. Impact of Mixed Aortic Valve Stenosis on VARC-2 Outcomes and Postprocedural Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation: results From the International Multicentric Study PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration). Catheter Cardiovasc Interv. 2015;86(5):875–885. doi:10.1002/ccd.25975
  • Abdelghani M, Cavalcante R, Miyazaki Y, et al. Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease. EuroIntervention. 2017;13(10):1157–1165. doi:10.4244/EIJ-D-17-00328
  • Chahine J, Kadri AN, Gajulapalli RD, et al. Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease. JACC: Cardiovasc Interv. 2019;12(22):2299–2306. doi:10.1016/j.jcin.2019.06.020
  • Heidari B, Al-Hijji MA, Alkhouli MA, et al. Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis. Int J Cardiol. 2020;299:209–214. doi:10.1016/j.ijcard.2019.07.099
  • Guddeti RR, Gill GS, Garcia-Garcia HM, et al. Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):169–176. doi:10.1093/ehjqcco/qcab080
  • Demirel C, Winter MP, Nitsche C, et al. Mixed aortic valve disease: association with paravalvular leak and reduced survival after TAVR. Eur Heart J Cardiovasc Imaging. 2024. doi:10.1093/ehjci/jeae005
  • Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: a Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–371. doi:10.1016/j.echo.2017.01.007
  • Baumgartner HC, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(3):254–275. doi:10.1093/ehjci/jew335
  • Li J, Sun Y, Zheng S, et al. Anatomical Predictors of Valve Malposition During Self-Expandable Transcatheter Aortic Valve Replacement. Front Cardiovasc Med. 2021;8:600356. doi:10.3389/fcvm.2021.600356
  • Stathogiannis K, Toutouzas K, Drakopoulou M, et al. The Effect of Mixed Aortic Valve Disease in Clinical Outcomes after Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2017;69(11):1223. doi:10.1016/S0735-1097(17)34612-0
  • Meredith IT, Walters DL, Dumonteil N, et al. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: results of the REPRISE II Study. JACC: Cardiovasc Interv. 2016;9(4):376–384. doi:10.1016/j.jcin.2015.10.024
  • Deeb GM, Reardon MJ, Chetcuti S, et al. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016;67(22):2565–2574. doi:10.1016/j.jacc.2016.03.506
  • Grant JK, Rubin P, Chambers S, et al. Comparison of In-Hospital Outcomes and Readmission Rates of Transcatheter Aortic Valve Implantation in Mixed Aortic Valve Disease Versus Pure Aortic Stenosis. Am J Cardiol. 2022;175:72–79. doi:10.1016/j.amjcard.2022.03.052
  • Seeger J, Gonska B, Mörike J, et al. Outcome of Patients with Mixed Aortic Valve Disease Undergoing Transfemoral Aortic Valve Replacement. Struct Heart. 2017;1(3–4):162–167. doi:10.1080/24748706.2017.1348648
  • Vianello A, Perlini S, Cappelli S, et al. A multimarker study of degenerative aortic valve disease: stenoinsufficiency shows more indices of bad prognosis. Cardiology. 2013;124(2):126–137.
  • Larroche J, Panh L, Lhermusier T, et al. Impact of aortic valve calcification severity on device success after transcatheter aortic valve replacement. Int J Cardiovasc Imaging. 2020;36(4):731–740. doi:10.1007/s10554-019-01759-7
  • Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–1595. doi:10.1016/j.jacc.2013.01.047
  • Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36(7):449–456. doi:10.1093/eurheartj/ehu384
  • Bhushan S, Huang X, Li Y, et al. Paravalvular Leak After Transcatheter Aortic Valve Implantation Its Incidence, Diagnosis, Clinical Implications, Prevention, Management, and Future Perspectives: a Review Article. Curr Probl Cardiol. 2022;47(10):100957. doi:10.1016/j.cpcardiol.2021.100957